Sífilis

  1. Martín Aspas, A. 1
  2. Soler Gómez, A. 1
  3. Corrales Cuevas, M. 1
  4. Caamaño Selma, O. 1
  1. 1 Servicio de Medicina Interna General, Enfermedades Infecciosas y Cuidados Paliativos. Hospital Universitario Puerta del Mar. Cádiz. España
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2022

Título del ejemplar: Enfermedades infecciosas (VI)

Serie: 13

Número: 54

Páginas: 3145-3156

Tipo: Artículo

DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

La incidencia de la sífilis ha aumentado notablemente en los últimos diez años. Sus síntomas y signos son muy variados, por lo que necesita un alto nivel de sospecha, especialmente para las formas clínicas de neurosífilis que se diagnostican mayoritariamente en fases precoces, por lo que es imprescindible una anamnesis y una exploración clínica neurológica adecuadas en todo paciente atendido por sífilis. El diagnóstico y el seguimiento se hacen fundamentalmente con serología, pero su correcta interpretación necesita una historia clínica dirigida a conductas sexuales de riesgo y antecedentes de sífilis y tratamiento de la misma. El tratamiento con penicilina parenteral sigue siendo eficaz y la primera opción terapéutica. Por su alta transmisibilidad, se debe estudiar y tratar a las parejas sexuales de las personas diagnosticadas de sífilis.

Referencias bibliográficas

  • Harper KN, Zuckerman MK, Harper ML, Kingston JD, Armelagos GJ. The origin and antiquity of syphilis revisited: an appraisal of Old World pre-Columbian evidence for treponemal infection. Am J Phys Anthropol. 2011;146 Suppl 53:99-133
  • Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev. 1999;12:187-209.
  • Tsuboi M, Evans J, Davies EP, Rowley J, Korenromp EL, Clayton T. Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000-20. Lancet Glob Health. 2021;9:e1110-e8.
  • Hossain M, Broutet N, Hawkes S. The elimination of congenital syphilis: a comparison of the proposed World Health Organization action plan for the elimination of congenital syphilis with existing national maternal and congenital syphilis policies. Sex Transm Dis. 2007;34Suppl7:S22-30.
  • Janier M, Unemo M, Dupin N, Tiplica GS, Potoˇcnik M, Patel R. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2021;35:574-88.
  • Dombrowski JC, Pedersen R, Marra CM, Kerani RP, Golden MR. Prevalence estimates of complicated syphilis. Sex Transm Dis. 2015;42:702-4.
  • Ropper AH. Neurosyphilis. N Engl J Med. 2019;381:1358-63.
  • Ho EL, Lukehart SA. Syphilis: using modern approaches to understand an old disease. J Clin Invest. 2011;121:4584-92.
  • Peterman TA, Kidd SE. Trends in deaths due to syphilis, United States, 1968-2015. Sex Transm Dis. 2019;46:37-40.
  • Rowns JM, Leslie DE, Denham I, Azzato F, Fairley CK, Chen M. Painful and multiple anogenital lesions are common in men with Treponema pallidum PCR-positive primary syphilis without herpes simplex virus coinfection: a cross-sectional clinic-based study. Sex Transm Infect. 2016;92:110-5.
  • Lampros A, Seta V, Gerhardt P, Isnard C, Husson C, Dupin N. Oral forms of secondary syphilis: An illustration of the pitfalls set by the great imitator. J Am Acad Dermatol. 2021;84:348-53.
  • Salado Rasmussen K, Wessman M, Cowan SA, Gerstoft J, Katzenstein TL. Syphilitic hepatitis and neurosyphilis: an observational study of Danish HIV-infected individuals during a 13-year period. Sex Transm Infect. 2019;95:416-8.
  • Marra CM, Ghanem KG. Centers for Disease Control and Prevention Syphilis Summit: Difficult Clinical and Patient Management Issues. Sex Transm Dis. 2018;45Suppl1:S10-S2.
  • Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I. Sexually Transmitted infections treatment guideli- nes, 2021. MMWR Recomm Rep. 2021;70:1-187.
  • Tuddenham S, Ghanem KG. Neurosyphilis: Knowledge gaps and controversies. Sex Transm Dis 2018;45:147-51.
  • Oliver SE, Aubin M, Atwell L, Matthias J, Cope A, Mobley V. Ocular syphilis-eight jurisdictions, United States, 2014-2015. MMWR Morb Mortal Wkly Rep. 2016;65:1185-8.
  • Klein A, Fischer N, Goldstein M, Shulman S, Habot Wilner Z. The great imitator on the rise: ocular and optic nerve manifestations in patients with newly diagnosed syphilis. Acta Ophthalmol. 2019;97:e641-e7.
  • Schulz DC, Orr SMA, Johnstone R, Devlin MK, Sheidow TG, Bursztyn LLCD. The many faces of ocular syphilis: case-based update on recognition, diagnosis, and treatment. Can J Ophthalmol. 2021: S0008-4182(21)00016-8.
  • Ramchandani MS, Litvack JR, Marra CM. Otosyphilis: A review of the literature. Sex Transm Dis. 2020;47:296-300.
  • Ghanem KG, Ram S, Rice PA. The modern epidemic of syphilis. N Engl J Med. 2020;382:845-54
  • Wicher V, Wicher K. Pathogenesis of maternal-fetal syphilis revisited. Clin Infect Dis. 2001;33:354-63.
  • Hong FC, Wu XB, Yang F, Lan LN, Guan Y, Zhang CL. Risk of Congenital syphilis (CS) following treatment of maternal syphilis: Results of a CS control program in China. Clin Infect Dis. 2017;65:588-94.
  • Medoro AK, Sánchez PJ. Syphilis in neonates and infants. Clin Perinatol. 2021;48:293-309.
  • Wheeler HL, Agarwal S, Goh BT. Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis. Sex Transm Infect. 2004;80:411-4.
  • Satyaputra F, Hendry S, Braddick M, Sivabalan P, Norton R. The laboratory diagnosis of syphilis. J Clin Microbiol. 2021:JCM.00100-21.
  • Brischetto A, Gassiep I, Whiley D, Norton R. Retrospective review of treponema pallidum PCR and serology results: Are both tests necessary? J Clin Microbiol. 2018;56:e01782-17.
  • Marra CM, Tantalo LC, Maxwell CL, Ho EL, Sahi SK, Jones T. The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis. Sex Transm Dis. 2012;39:453-7.
  • Luo Y, Xie Y, Xiao Y. Laboratory diagnostic tools for syphilis: Current status and future prospects. Front Cell Infect Microbiol. 2020;10:574806.
  • Boog GHP, Lopes JVZ, Mahler JV, Solti M, Kawahara LT, Teng AK. Diagnostic tools for neurosyphilis: a systematic review. BMC Infect Dis. 2021;21:568.
  • Tong ML, Lin LR, Liu GL, Zhang HL, Zeng YL, Zheng WH. Factors associated with serological cure and the serofast state of HIV- negative patients with primary, secondary, latent, and tertiary syphilis. PLoS One. 2013;8:e70102.
  • Liu LL, Lin LR, Tong ML, Zhang HL, Huang SJ, Chen YY. Incidence and risk factors for the prozone phenomenon in serologic testing for syphilis in a large cohort. Clin Infect Dis. 2014;59:384-9.
  • Peng J, Lu Y, Yu H, Wu S, Li T, Li H. Analysis of 2 reverse syphilis testing algorithms in diagnosis of syphilis: A large-cohort prospective study. Clin Infect Dis 2018;67:947-53.
  • Causer LM, Kaldor JM, Conway DP, Leslie DE, Denham I, Karapanagiotidis T. An evaluation of a novel dual treponemal/nontreponemal point-of-care test for syphilis as a tool to distinguish active from past treated infection. Clin Infect Dis. 2015;61:184-91
  • Van Den Heuvel A, Smet H, Prat I, Sands A, Urassa W, Fransen K. Laboratory evaluation of four HIV/syphilis rapid diagnostic tests. BMC Infect Dis. 2019;19:1.
  • Rotman L, Luo X, Thompson A, Mackesy Amiti ME, Young LR, Young JD. Risk of neurosyphilis in HIV-infected persons with syphilis lacking signs or symptoms of central nervous system infection. HIV Med. 2019;20:27-32.
  • Tomkins A, Ahmad S, Cousins DE, Thng CM, Vilar FJ, Higgins SP. Screening for asymptomatic neurosyphilis in HIV patients after treatment of early syphilis: an observational study. Sex Transm Infect. 2018;94:337-9.
  • Harding AS, Ghanem KG. The performance of cerebrospinal fluid treponemal-specific antibody tests in neurosyphilis: a systematic review. Sex Transm Dis. 2012;39:291-7.
  • Antonio MB, Cuba GT, Vasconcelos RP, Alves APPS, da Silva BO, Avelino Silva VI. Natural experiment of syphilis treatment with doxycycline or benzathine penicillin in HIV-infected patients. AIDS. 2019;33:77-81.
  • Liu HY, Han Y, Chen XS, Bai L, Guo SP, Li L. Comparison of efficacy of treatments for early syphilis: A systematic review and network meta-analysis of randomized controlled trials and observational studies. PLoS One. 2017;12:e0180001.
  • Dai T, Qu R, Liu J, Zhou P, Wang Q. Efficacy of doxycycline in the treatment of syphilis. Antimicrob Agents Chemother. 2017; 61:e01092-16
  • Cao Y, Su X, Wang Q, Xue H, Zhu X, Zhang C. A multicenter study evaluating ceftriaxone and benzathine penicillin G as treatment agents for early syphilis in Jiangsu, China. Clin Infect Dis. 2017;65:1683-8.
  • Liang Z, Chen YP, Yang CS, Guo W, Jiang XX, Xu XF. Meta-analysis of ceftriaxone compared with penicillin for the treatment of syphilis. Int J Antimicrob Agents. 2016;47:6-11.
  • Mikalová L, Grillová L, Osbak K, Strouhal M, Kenyon C, Crucitti T. Molecular typing of syphilis-causing strains among human immunodeficiency virus-positive patients in Antwerp, Belgium. Sex Transm Dis. 2017;44:376-9.
  • Pospíšilová P, Grange PA, Grillová L, Mikalová L, Martinet P, Janier M. Multi-locus sequence typing of Treponema pallidum subsp. pallidum present in clinical samples from France: Infecting treponemes are genetically diverse and belong to 18 allelic profiles. PLoS One. 2018;13:e0201068.
  • Giacani L, Ciccarese G, Puga Salazar C, Dal Conte I, Colli L, Cusini M. Enhanced molecular typing of Treponema pallidum subspecies pallidum strains from 4 Italian hospitals shows geographical differences in strain type heterogeneity, widespread resistance to macrolides, and lack of mutations associated with doxycycline resistance. Sex Transm Dis. 2018;45:237-42.
  • Marra CM, Maxwell CL, Tantalo LC, Sahi SK, Lukehart SA. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis. 2008;47:893-9.
  • Xiao Y, Tong ML, Lin LR, Liu LL, Gao K, Chen MJ. Serological response predicts normalization of cerebrospinal fluid abnormalities at six months after treatment in HIV-negative neurosyphilis patients. Sci Rep. 2017;7:9911.
  • Zhang X, Shahum A, Yang LG, Xue Y, Wang L, Yang B. Outcomes from re-treatment and cerebrospinal fluid analyses in patients with syphilis who had serological nonresponse or lack of seroreversion after initial therapy. Sex Transm Dis. 2021;48:443-50.
  • Pastuszczak M, Sitko M, Bociaga Jasik M, Kucharz J, Wojas Pelc A. Lack of antiretroviral therapy is associated with higher risk of neurosyphilis among HIV-infected patients who remain serofast after therapy for early syphilis. Medicine (Baltimore). 2018;97:e13171.
  • Hobbs E, Vera JH, Marks M, Barritt AW, Ridha BH, Lawrence D. Neurosyphilis in patients with HIV. Pract Neurol. 2018;18:211-8.
  • Ren M, Dashwood T, Walmsley S. The intersection of HIV and syphilis: Update on the key considerations in testing and manage- ment. Curr HIV/AIDS Rep. 2021;18:280-8.
  • Wöhrl S, Geusau A. Neurosyphilis is unlikely in patients with late latent syphilis and a negative blood VDRL-test. Acta Derm Venereol. 2006;86:335-9.
  • Tuddenham S, Obeng C, Ghanem KG. Neurosyphilis and ophthalmic syphilis in persons with negative rapid plasma reagin and positive treponemal antibody test results. Sex Transm Dis. 2015;42:347-9.
Fuente de los datos: Dialnet